FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to immunology and allergology, and can be used in treating allergic diseases. That is ensured by preliminary recovery of self-lymphocytes from venous blood of the patient. Then self-lymphocyte suspension in physiologic saline is introduced subcutaneously in lateral surface of the humerus in dosages 0.1 to 1.0 ml with the concentration of self-lymphocytes 105-107 c/ml. Introduction is performed 4 to 10 times every 2 to 6 days.
EFFECT: method allows considerably cutting time of treatment, prolonging remission, and avoiding potential by-effects.
2 cl, 6 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
METHOD FOR ALLERGIC DISEASE TREATMENT | 0 |
|
SU1793923A3 |
METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
METHOD OF TREATING CHRONIC RECURRENT UROGENITAL BACTERIAL AND VIRAL DISEASES | 2009 |
|
RU2390339C1 |
METHOD OF TREATMENT OF BRONCHIAL ASTHMA | 2017 |
|
RU2652752C1 |
METHOD FOR TREATMENT OF PATIENTS WITH ALLERGIC DISEASES BY AUTOLOGICAL LYMPHOCYTES | 2015 |
|
RU2633343C2 |
METHOD FOR TREATING ATOPIC BRONCHIAL ASTHMA | 2003 |
|
RU2236849C2 |
METHOD OF TREATING ALLERGIC DISEASES | 2020 |
|
RU2742976C1 |
METHOD FOR TREATMENT AND PREVENTION OF ALLERGIC SPECTRUM STATES | 2016 |
|
RU2635968C1 |
METHOD FOR EVALUATING EFFECTIVENESS OF TREATMENT OF BRONCHIAL ASTHMA | 2008 |
|
RU2389023C2 |
Authors
Dates
2010-07-27—Published
2009-03-30—Filed